Dissolving heart scaffolds put to the test in massive Real-World study
NCT ID NCT03327961
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing absorbable scaffolds—temporary tubes that support blocked heart arteries and then dissolve over time—in over 1,100 people with coronary artery disease. Researchers are tracking heart-related deaths, heart attacks, and the need for repeat procedures to see how safe and effective these scaffolds are in everyday medical practice. Participants must be over 18, have at least one scaffold implanted, and agree to follow-up for at least one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- absorbable scaffold (e.g., Magmaris, Desolve)
- What this could lead to
- If successful, this could show that absorbable scaffolds are a safe and effective option for treating blocked arteries, potentially reducing the need for permanent metal stents.
- What could go wrong
- This is an observational study, not a randomized trial, so results may not prove superiority over standard stents. Risks include blood clots, vessel re-narrowing, and the need for long-term anti-clotting medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AO San Giovanni di Dio
RECRUITINGAgrigento, Agrigento, Italy
-
AOU San Luigi Gonzaga
RECRUITINGOrbassano, Torino, Italy
-
Azienda Ospedaliera Universitaria di Bologna
RECRUITINGBologna, Bologna, Italy
-
Maria Cecilia Hospital - GVM Care & Research
RECRUITINGCotignola, Ravenna, Italy
-
Ospedale Caravaggio-Treviglio
RECRUITINGTreviglio, Bergamo, Italy
-
Ospedale Guglielmo da Saliceto
RECRUITINGPiacenza, Piacenza, Italy
-
Ospedale SS Annunziata
RECRUITINGSavigliano, Cuneo, Italy
-
Ospedale di Rivoli
RECRUITINGRivoli, Torino, Italy
-
Ospedale di Sanremo
RECRUITINGSanremo, Italy
-
U.O. Cardiologia, Azienda Ospedaliera Universitaria di Modena, Policlinico
RECRUITINGModena, Modena, Italy
-
U.O. Cardiologia, Ospedale Maggiore
RECRUITINGBologna, Bologna, Italy
-
U.O. Cardiologia, Ospedale Morgagni Pierantoni
RECRUITINGForlì, Forlì-Cesena, Italy
-
U.O. Cardiologia, Ospedale di Baggiovara
RECRUITINGModena, Modena, Italy
-
U.O. di Cardiologia, Azienda Ospedaliero-Universitaria di Parma
RECRUITINGParma, Parma, Italy
-
U.O. di Cardiologia, Ospedale Santa Maria delle Croci
RECRUITINGRavenna, Ravenna, Italy
-
U.O. di Cardiologia, Ospedale degli Infermi
RECRUITINGRimini, Rimini, Italy
-
University Hospital of Ferrara
RECRUITINGCona, Ferrara, 44124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?